Position in BBIO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,352,334
-$517,570 QoQ
Shares Held
31,677
-15.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $466,757,935 across 164 Biotechnology names. BBIO ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
373,532 | $166,796,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
152,397 | $117,748,018 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,013 | $57,575,681 | |
| 4 | INSM |
INSMED Inc
|
283,141 | $46,299,216 | |
| 5 | INCY |
Incyte Corp
|
49,678 | $4,675,693 | |
| 6 | MRNA |
Moderna, Inc.
|
71,342 | $3,624,173 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
This page
|
31,677 | $2,352,334 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
31,498 | $1,974,924 |
All Filings in BBIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,352,334 | 31,677 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,869,904 | 37,520 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,742,587 | 33,550 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,690,756 | 39,156 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,348,921 | 39,020 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,331,910 | 48,539 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $959,205 | 37,675 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $688,393 | 27,177 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,029,048 | 33,281 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,214,006 | 30,072 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $672,514 | 25,503 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $434,816 | 25,280 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $380,610 | 22,956 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $198,013 | 25,986 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $238,569 | 24,001 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $227,181 | 25,020 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $382,015 | 37,637 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $777,371 | 46,605 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,267,148 | 48,371 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,337,194 | 54,744 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,828,795 | 45,922 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,492,405 | 35,050 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,074,797 | 28,646 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $955,212 | 29,292 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $620,542 | 21,398 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||